PMC:7029759 / 24707-24870 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"555","span":{"begin":25,"end":29},"obj":"Gene"},{"id":"556","span":{"begin":47,"end":51},"obj":"Gene"},{"id":"557","span":{"begin":125,"end":129},"obj":"Gene"},{"id":"569","span":{"begin":74,"end":82},"obj":"Species"}],"attributes":[{"id":"A555","pred":"tao:has_database_id","subj":"555","obj":"Gene:59272"},{"id":"A556","pred":"tao:has_database_id","subj":"556","obj":"Gene:59272"},{"id":"A557","pred":"tao:has_database_id","subj":"557","obj":"Gene:59272"},{"id":"A569","pred":"tao:has_database_id","subj":"569","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"has similar affinity for ACE2. In order to use ACE2 as a therapy to treat patients, it would be advisable to convert soluble ACE2 into an immunoadhesin format fuse"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T600","span":{"begin":25,"end":29},"obj":"G_3;PG_10;PR:000003622"},{"id":"T599","span":{"begin":47,"end":51},"obj":"G_3;PG_10;PR:000003622"},{"id":"T598","span":{"begin":125,"end":129},"obj":"G_3;PG_10;PR:000003622"}],"text":"has similar affinity for ACE2. In order to use ACE2 as a therapy to treat patients, it would be advisable to convert soluble ACE2 into an immunoadhesin format fuse"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T220","span":{"begin":0,"end":3},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T221","span":{"begin":55,"end":56},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"has similar affinity for ACE2. In order to use ACE2 as a therapy to treat patients, it would be advisable to convert soluble ACE2 into an immunoadhesin format fuse"}